Lack of prognostic significance for major adverse cardiac events of soluble suppression of tumorigenicity 2 levels in patients with ST-segment elevation myocardial infarction

BACKGROUND: Elevation of soluble suppression of tumorigenicity 2 (sST2) is associated with cardiac fibrosis and hypertrophy. Under investigation herein, was whether sST2 level is associated with major adverse cardiac events (MACE) and left ventricular (LV) remodeling after primary percutaneous coron...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cardiol J
Autors principals: Kim, Min, Lee, Dae In, Lee, Ju-Hee, Kim, Sang Min, Lee, Sang Yeub, Hwang, Kyung-Kuk, Kim, Dong-Woon, Cho, Myeong-Chan, Bae, Jang-Whan
Format: Artigo
Idioma:Inglês
Publicat: Via Medica 2021
Matèries:
Clinical Cardiology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8078943/
https://ncbi.nlm.nih.gov/pubmed/32104902
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5603/CJ.a2020.0028
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars